Skip to main content
. 2021 Oct 8;8:668697. doi: 10.3389/fmed.2021.668697

Figure 4.

Figure 4

(A) Differences of CA19-9 between malignant and benign groups, ***P < 0.001; (B) ROC curves of CA19-9 and SUVmax.